Les médicaments marqués en jaune ont la description texte.
- ABRILADA /solution/: adalimumab (40)
- ABRILADA /solution/: adalimumab (40)
- ABRILADA /solution/: adalimumab (20)
- AMGEVITA /solution/: adalimumab (50)
- AMGEVITA /solution/: adalimumab (50)
- AMGEVITA /solution/: adalimumab (50)
- HADLIMA /solution/: adalimumab (40)
- HADLIMA /solution/: adalimumab (40)
- HADLIMA PUSHTOUCH /solution/: adalimumab (40)
- HADLIMA PUSHTOUCH /solution/: adalimumab (40)
- HULIO /solution/: adalimumab (40)
- HULIO /solution/: adalimumab (20)
- HULIO /solution/: adalimumab (40)
- HUMIRA /solution/: adalimumab (40)
- HUMIRA /solution/: adalimumab (20)
- HYRIMOZ /solution/: adalimumab (20)
- HYRIMOZ /solution/: adalimumab (40)
- HYRIMOZ /solution/: adalimumab (40)
- IDACIO /solution/: adalimumab (40)
- IDACIO /solution/: adalimumab (40)
- SIMLANDI /solution/: adalimumab (40)
- SIMLANDI /solution/: adalimumab (40)
- SIMLANDI /solution/: adalimumab (80)
- YUFLYMA /solution/: adalimumab (80)
- YUFLYMA /solution/: adalimumab (80)
- YUFLYMA /solution/: adalimumab (40)
- YUFLYMA /solution/: adalimumab (40)
27 médicaments correspondent à la recherche.